Randy is a Scientist II, Viral Vector Process Development in the Technical Operations team. In 15+ years in the industry, he has held roles in production and process development at The Allen Institute, CMC Biologics (now AGC), Dendreon, and Silverback Therapeutics. At CMC Biologics, he developed and characterized purification processes for biosimilars. During his time at Dendreon, he worked on early and commercial stage processes for cellular immunotherapies and biologics. Most recently, he helped guide early phase development and manufacturing of three early-stage antibody drug conjugates at Silverback Therapeutics. Randy was born and raised in Seattle and obtained his BS in Biochemistry from The University of Washington.
Randy Ng, BS